Leistritz Hosts Extrusion Seminar

Article

The company will hold its annual extrusion seminar in June 2017.

Leistritz will host its 12th annual Pharmaceutical Extrusion Seminar on June 7–8, 2017. Classroom sessions will be held at the Holiday Inn Select in Clinton, NJ, and extrusion demonstrations at the Leistritz Process Laboratory in Somerville, NJ. In addition to melt extrusion and granulation processes, a special focus will be on multi-functional medical devices. Leistritz staff and outside industry experts will contribute to the program content. Some of the topics include:

  • Twin screw extrusion theory and design

  • Comparison of co-rotating and counterrotating twin screw extruder technologies

  • Downstream systems for pelletizing, tubes, filaments, films, molding, and unique shape extrusion

  • Die design and computer modeling

  • Single screw extrusion theory and design

  • Upstream equipment designs for feeding, material handling, and containment

  • Staging of unit operations in an extrusion system to facilitate continuous compounding and part fabrication

  • Scale-up of the extrusion process-R&D, pilot scale, and production

  • Cleaning and maintenance of extrusion equipment in a cGMP environment

  • Equipment and process validation practices and documentation

  • Advantages of continuous extrusion as compared to batch processes

  • Mixing techniques for poorly soluble and heat/shear sensitive APIs

  • New emerging extrusion technologies (i.e., supercritical foaming and co-extrusion).

Source: Leistritz 

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content